Trial · NCT03197662
Outcomes14
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Efficacy of Peptide Intranasal Oxytocin (IN-OXT) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
| SECONDARY | Change in Repetitive Behavior | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
| SECONDARY | Change in Rigid Behavior | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
| SECONDARY | Change in Body Weight | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | kilograms | MEAN |
| SECONDARY | Body Composition | 8 weeks | Data was missing or unable to be collected from 4 participants in the IN-OXT study arm and 8 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | percentage of fat | MEDIAN |
| SECONDARY | Change in Body Mass Index (BMI) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 1 participant in the IN-OXT arm and 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | kg/m2 | MEAN |
| SECONDARY | Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire: Domain 1 (Physical Health) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 1 participant in the IN-OXT arm and 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 2 (Psychological Health) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 1 participant in the IN-OXT arm and 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 3 (Social Relationships) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 1 participant in the IN-OXT arm and 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | score on a scale | MEAN |
| SECONDARY | Change in Quality of Life (QOL) and Caregiver Burden as Determined by the World Health Organization Quality of Life (WHOQOL-BREF) Questionnaire - Domain 4 (Environment) | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was missing or unable to be collected from 1 participant in the IN-OXT arm and 3 participants in the matched Placebo study arm (including the 2 participants who withdrew from the study). | score on a scale | MEAN |
| SECONDARY | Change in Caregiver Strain | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
| SECONDARY | Change in Aberrant Behavior | From Randomization at Baseline until Endpoint at Week 8 (Change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
| SECONDARY | Change in Salivary Oxytocin Concentration | From Baseline until collections at 1 hour (Day 1), Week 4 and Week 8 | Due to challenges in collecting saliva samples from this population, participants were not able to provide enough saliva to allow for appropriate analysis. As such, samples were not obtained and data was unable to be collected. | ||
| SECONDARY | Clinical Global Impression Scale - Improvement (CGI-I) | 8 weeks (measuring change over 8 weeks) | Data was unable to be collected from 2 participants in the matched Placebo study arm who withdrew from the study. | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197662/outcomes